Global  

UK health workers begin hydroxychloroquine trial

Video Credit: Reuters Studio - Duration: 01:25s - Published
UK health workers begin hydroxychloroquine trial

UK health workers begin hydroxychloroquine trial

British healthcare workers will on Thursday begin taking part in a University of Oxford-led international trial of two anti-malarial drugs to see if they can prevent COVID-19, including one U.S. President Donald Trump says he has been taking.

Olivia Chan reports.

0
shares
ShareTweetSavePostSend
 

EDITORS PLEASE NOTE: ORIGINAL EDIT CONTAINED SHOTS OF A LAB UNRELATED TO THE ANTI-MALARIAL DRUGS MENTIONED IN THE STORY.

THEY HAVE BEEN REPLACED BY STILLS OF THE RELEVANT ANTI-MALARIAL DRUGS.

British healthcare workers will begin taking part in a trial on Thursday (May 21) to determine if two anti-malarial drugs can prevent COVID-19.

It includes chloroquine and hydroxychloroquine, the same drug which U.S. President Donald Trump says he is taking.

The "COPCOV" trial is an international study led by the University of Oxford, with support of a tropical medicine unit in Bangkok.

It will be open to British participants who are in close contact with patients with proven or suspected COVID-19... ...with a total of 25 study sites expected to open in the UK by the end of June.

Plans have been put in place for further test sites in Southeast Asia, Italy, Portugal, Africa, and South America.

Forty-thousand frontline healthcare workers will be involved.

So far, the COPCOV team says lab evidence showed these drugs might be effective in preventing or treating coronavirus, but there was no conclusive proof.

The best way to find out its effectiveness is in a randomized clinical trial.

The results are expected by the end of this year.

U.S. regulators have authorized the emergency use of hydroxychloroquine... But the authorities has also warned against the use of it in COVID-19 patients outside of the hospital or clinical trials due to the risk of serious heart rhythm problems.



Related news from verified sources

UK healthcare workers begin COVID-19 hydroxychloroquine trial

Study aims to determine if chloroquine and hydroxychloroquine are effective in preventing the novel...
Al Jazeera - Published

What is the Trump-endorsed drug being trialled for UK Covid-19 treatment?

A global trial involving UK health workers of an anti-malarial drug to test its efficacy against the...
Belfast Telegraph - Published


You Might Like


Tweets about this


Related videos from verified sources

Local health care workers participate in nationwide hydroxychloroquine trial [Video]

Local health care workers participate in nationwide hydroxychloroquine trial

Not the easiest name to pronounce, but that hasn’t stopped hydroxychloroquine from being one of the most talked about drugs this year.

Credit: NewsChannel 5 Nashville     Duration: 02:06Published